Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sichuan dark tea is a traditional post-fermented tea produced from Camellia sinensis leaves in Sichuan province, China, particularly known as Ya'an South-road Dark Tea (SSDT) or Zangcha. It undergoes a unique microbial solid-state fermentation, resulting in characteristic flavors, colors, and bioactive chemical composition. Rich in polyphenols, catechins, amino acids, caffeine, and unique metabolites, Sichuan dark tea has reported biological activities including lowering blood lipids, improving lipid metabolism, modulating gut microbiota, exhibiting anti-hyperglycemic, antihypertensive, anti-atherogenic and possible anti-obesity effects. Mechanistically, its effects are attributed to modulation of metabolic and regulatory pathways such as AMPK activation, increased HDL, reduced triglycerides, increased expression of cholesterol efflux proteins (ABCA1), activation of fatty acid oxidation genes (PPARα, PPARγ, LXRα), and gut microbiota modulation. It is used both as a beverage and in traditional medicine for prevention and adjunct management of metabolic and cardiovascular diseases[1][2][4][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sichuan dark tea.